Dental News

Must know: Fatal Dental Drug Interactions for Covid-19 patients

According to a literature review published on September 24 in the European Review for Medical and Pharmacological Sciences , there are numerous drugs...

Dr. Rockson Samuel

Dr. Rockson Samuel

Founder & Chief Dentist · Indira Dental Clinic; DentalReach

2 min read42,946 views
  • covid-19
  • dental drugs
  • remdesivir
  • professional education
  • Dental Pharmacology & Safety
  • drug interactions
  • dentistry
  • antibiotics in dentistry
  • liver damage
  • Dental News

According to a literature review published on September 24 in the European Review for Medical and Pharmacological Sciences, there are numerous drugs prescribed in dentistry that caninteract moderately with Remdesivir.

"It is clinically necessary for oral health professionals to be aware of possible drug interactions that may occur between remdesivir and drugs commonly prescribed in dentistry in order to prevent adverse reactions that may even endanger the life of a patient with COVID-19,” wrote author Dr. Gerardo Gómez-Moreno, Ph.D., from the University of Granada School of Dentistry in Spain.

The medication may cause serious medical conditions when combined with drugs commonly prescribed by dentists. To get a better idea of the risk, Gómez-Moreno conducted a literature review to identify potential pharmacological interactions between remdesivir and the drugs prescribed in dentistry. The research reported up to July 31, 2020, was included in the review.

A LONG LIST OF DRUGS!

There are as many as 279 drugs, routinely prescribed in dentistry that are known to cause interaction with the anti-viral drug.

1. Alcohol:

Alcohol which is present in many antseptic mouthwashes which have been shown to reduce the viral load in COVID-19 patients, should be avoided if patients are being treated with remdesivir. The drug's interaction with alcohol mainly involves liver problem with symptoms like:

  • Fever,
  • Chills,
  • Joint pain or swelling,
  • Nausea,
  • Unusual bleeding or bruising,
  • Skin rash,
  • Pale stools and/or
  • Yellowing of the skin or eyes.

2. Antibiotics:

The following antibiotics cause chemical-induced liver damage when taken with remdesivir and therefore should be avoided:

  • Azithromycin,
  • Clavulanate,
  • Doxycycline,
  • Erythromycin,
  • Levofloxacin.

3. Antifungals:

These antifungals are potent enzyme inhibitors that can lead to spikes in blood plasma levels of remdesivir, which may result in liver damage.

  • Clotrimazole,
  • Fluconazole,
  • Itraconazole,
  • Ketoconazole.

4. Non steroidal anti-inflammatory drugs (NSAIDs)

The combination of the following drugs with remdesivir puts patients at major risk of liver damage:

  • Diclofenac,
  • Etodolac,
  • Flurbiprofen,
  • Ibuprofen,
  • Ketoprofen,
  • Ketorolac,
  • Mefenamic acid,
  • Naproxen,
  • Piroxicam.

Thus, it is mandatory that dentists are aware of the potential risk of pharmacological interactions between remdesivir and the drugs prescribed by them so that they can seek alternatives.

References

  1. [1]World Health Organization. Global Strategy and Action Plan on Oral Health 2023–2030 World Health Organization. 2024. Available at: source
  2. [2]FDI World Dental Federation. Vision 2030: Delivering Optimal Oral Health for All FDI World Dental Federation. 2021. Available at: source

Written by

Dr. Rockson Samuel

Dr. Rockson Samuel

Founder & Chief Dentist · Indira Dental Clinic; DentalReach

Dr. Rockson Samuel is a dental surgeon, healthcare content strategist, and Founder and Chief Dentist of Indira Dental Clinic in Vellore, Tamil Nadu. He provides comprehensive general and family dental care with professional interests in endodontics, implant dentistry, clear aligner therapy, digital dentistry, preventive care and patient education. A graduate of K.G.F. College of Dental Sciences and Hospital under Rajiv Gandhi University of Health Sciences, he also has formal training in management and digital marketing. As Community Leader at DentalReach, he contributes to dental publishing, professional education, international media partnerships and the development of evidence-informed resources for dentists.